Showing results (81-90 of 141) with videos related to

Sort By:
Pageof 15
Auto- Immunity Highlights|May 23, 2015
Pathogenesis and potential therapeutic targets in systemic lupus erythematosus: from bench to bedsideD Squatrito, G Emmi, E Silvestri, et al.
Auto- Immunity Highlights|May 23, 2015
Assessment of patients with idiopathic inflammatory myopathies and isolated creatin-kinase elevationL Iaccarino, E Pegoraro, L Bello, et al.
Auto- Immunity Highlights|November 16, 2016
Anti-rods/rings autoantibody seropositivity does not affect response to telaprevir treatment for chronic hepatitis C infectionS John Calise, Nicola Bizzaro, Thuy Nguyen, et al.
Auto- Immunity Highlights|March 22, 2017
The universe of ANA testing: a case for point-of-care ANA testingKonstantin N Konstantinov, Robert L Rubin
Auto- Immunity Highlights|March 26, 2017
Exploring the plasmatic platelet-activating factor acetylhydrolase activity in patients with anti-phospholipid antibodiesMartina Fabris, Adriana Cifù, Cinzia Pistis, et al.
Auto- Immunity Highlights|March 7, 2021
Sustained clinical remission under infliximab/rituximab combination therapy in a patient with granulomatosis with polyangiitisLarissa Valor-Méndez, Arnd Kleyer, Jürgen Rech, et al.
Auto- Immunity Highlights|March 5, 2020
The perspective on standardisation and harmonisation: the viewpoint of the EASI presidentJan Damoiseaux
Auto- Immunity Highlights|March 5, 2020
Receptor autoimmunity: diagnostic and therapeutic implicationsRenato Tozzoli
Auto- Immunity Highlights|March 28, 2021
Endogenous mitochondrial double-stranded RNA is not an activator of the type I interferon response in human pancreatic beta cellsAlexandra Coomans de Brachène, Angela Castela, Anyïshai E Musuaya, et al.
Auto- Immunity Highlights|April 8, 2020
Neutrophil/lymphocyte ratio and lymphocyte/monocyte ratio in ulcerative colitis as non-invasive biomarkers of disease activity and severityAshraf M Okba, Mariam M Amin, Ahmed S Abdelmoaty, et al.
Pageof 15